Drugs Made In America Acquisition II Corp. (DMIIR)

NGM

Closing price as of 2026-06-11 · Source: TEK2day Finance

Key Metrics

About Drugs Made In America Acquisition II Corp.

Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York, New York.